Records containing: Nonalcoholic Fatty Liver Disease (NAFLD)
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-07-31A Three-Part, Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single and Multiple Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ALN-PNP siRNA in Participants With Nonalcoholic Fatty Liver Disease (NAFLD) and a PNPLA3 Genetic Risk Factor
-
CLINICAL_TRIALS study record update · 2025-07-30The Impact of Pectin Supplementation on Systematic Inflammation Pathway, Gut Microbiome, and Metabolic Health in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Randomised, Placebo-Controlled, Dietary Intervention Study
-
CLINICAL_TRIALS study record update · 2025-07-23Randomized Comparative Clinical Study of the Dietary Supplement "Gepaktiv" (International Name: Phenomenon) in Comparison With Ursodeoxycholic Acid (UDCA) and Ademetionine in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) and Hepatomegaly
-
CLINICAL_TRIALS study record update · 2025-03-18Quantitative Ultrasound Techniques for Diagnosis of Nonalcoholic Steatohepatitis
-
CLINICAL_TRIALS study record update · 2024-09-19Efficacy, Safety and Mechanism of Action of Lanifibranor (IVA337) in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2024-03-13Lipid Metabolism, Lipotoxicity and Nonalcoholic Fatty Liver Disease: Implication of Postprandial Cytotoxic Lipids
-
CLINICAL_TRIALS study record update · 2022-11-22Growth Hormone and Intrahepatic Lipid Content in Patients With Nonalcoholic Fatty Liver Disease
-
CLINICAL_TRIALS study record update · 2022-10-13A Phase 2B Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of BMS-986036 (PEG-FGF21) in Adults With Nonalcoholic Steatohepatitis (NASH) and Compensated Liver Cirrhosis
-
CLINICAL_TRIALS study record update · 2022-09-09A Phase 2B Randomized Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of BMS-986036 (PEG-FGF21) in Adults With Nonalcoholic Steatohepatitis (NASH) and Stage 3 Liver Fibrosis
-
CLINICAL_TRIALS study record update · 2022-08-31Impact of Fructose on Metabolism, Energy Homeostasis and Magnetic Resonance (MR) Biomarkers in Nonalcoholic Fatty Liver Disease (NAFLD)
-
CLINICAL_TRIALS study record update · 2022-02-02A Proof of Concept, Open-Label Study Evaluating the Safety, Tolerability, and Efficacy of Regimens in Subjects With Nonalcoholic Steatohepatitis (NASH)
-
CLINICAL_TRIALS study record update · 2021-01-05Anti-LPS Antibody in Pediatric Nonalcoholic Fatty Liver Disease
-
CLINICAL_TRIALS study record update · 2020-01-13Tesamorelin Effects on Liver Fat and Histology in HIV: A Collaborative UO1 Grant
-
CLINICAL_TRIALS study record update · 2019-08-16Predictors of Improvement of Nonalcoholic Fatty Liver Disease in Morbidly Obese Patients Undergoing Bariatric Surgery
-
CLINICAL_TRIALS study record update · 2019-01-31Multimodal Approach in IBD Patients
-
CLINICAL_TRIALS study record update · 2018-09-20Comparison of Magnetic Resonance and Ultrasound Elastography With Liver Biopsy for Noninvasive Staging of Liver Fibrosis
-
CLINICAL_TRIALS study record update · 2018-05-16Screening With FibroTouch for Advanced Liver Fibrosis in NAFLD Patients With Underlying Type 2 Diabetes：A Registry and Diagnostic Cohort Study
-
CLINICAL_TRIALS study record update · 2018-02-07The Effect of Ezetimibe-Ursodiol Combination Therapy on Biomarkers of Liver Function and Sterol Balance in Subjects With NAFLD
-
CLINICAL_TRIALS study record update · 2017-09-05Cysteamine Bitartrate Delayed-Release for the Treatment of Nonalcoholic Fatty Liver Disease (NAFLD) in Children (CyNCh)
-
CLINICAL_TRIALS study record update · 2015-08-21The Farnesoid X Receptor (FXR) Ligand Obeticholic Acid in Nonalcoholic Steatohepatitis (NASH) Treatment (FLINT) Trial
-
CLINICAL_TRIALS study record update · 2014-08-11Evaluation of Perindopril and Telmisartan for the Treatment of Nonalcoholic Fatty Liver Disease: A Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2014-05-28Metformin Versus Atorvastatin in Nonalcoholic Hepatic Steatosis: a Randomized Study